Skip to content
★ Sign in to follow
Vijaya Diagnostic Centre Limited logo

Vijaya Diagnostic Centre Limited Stock: price and insider trades · India

IN·Mcap ₹150.9BHealth Care

1 insider bought shares over the last 90 days, the latest by HDFC Mutual Fund, filed 13 Aug 2026.

Vijaya Diagnostic Centre Limited: what insiders have been doing

Vijaya Diagnostic Centre Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). 2 insiders have disclosed 2 filings since 29 October 2025.

The record shows 1 purchase on the open market, made by 1 insider, against 1 sale by 1 insider. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

For context, the typical company on the same exchange (median of 1,894 companies) published 4 filings over the same period, against 2 filings here. Over the whole record (from 2022), the tally stands at 9 purchases and 2 sales.

The last purchase on record was published on 13 August 2026, which is 87 days ago.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
11
Thresholds
n/a
Buy Volume
€1M
9 ops. · all time
Sell Volume
€14,557
2 ops. · all time

Who traded when

BuySale
abrdn Asia Ltd1 sale
HDFC Mutual Fund1 buy

Since the insiders bought

  • Filed 28 Jun 2022 · 1594 days ago · €123k
    +40.4%
    Entry ₹336.60 · Close at T+365 ₹472.70

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Vijaya Diagnostic Centre Limited Strong Buy (bullish), based on 10 analysts. Average price target: ₹1,554.80.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 11,274 of 26,914 companies
55.7
score / 100
Value
28
Quality
83
FCF yld0.6%
Earn yld1.1%
EV/EBITDA43.7x
ROE21%
Gross mgn88%
Net mgn21%
Debt/EBITDA1.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹1,465.30
Analyst consensus
10 analysts
Strong buy
₹1,400.00Target ₹1,554.80(+6%)₹1,700.00
Income statement
Revenue₹8.1B
Gross profit₹7.2B88% margin
EBITDA₹3.6B44% margin
Net income₹1.7B21.9% margin
Valuation
PER (trailing)80.6x
PER (forward)53.2x
P/Book15.7x
Beta0.36
Balance sheet & cash
Market cap₹150.9B
Total debt₹4.2B
Free Cash Flow₹878.8M
Debt / Equity44%
Profitability & ownership
ROE19.7%
ROA11.0%
% insiders53.5%
% institutions39.6%
Last declaration on 13 August 2026
Declarations11 total
  • ▼
    Related company / holdingExecutives
    0SEBI
    133,199 shares-MarketSEBI:737271e54cfd024ccb1d6e2b84ae3260ec7038a0
  • ▲
    Related company / holdingExecutives
    0SEBI
    6,340 shares-MarketSEBI:95d25238eec374b2718791d0740dadb336a077fe
    Canonical exit: 11 Nov 2026 (T+90)
  • ▼
    Executives
    1M INR10SEBI
    3,000 shares@ ₹432.5627100.0% of flowEquity SharesSEBI:e5a84d8189c6b61c15c16950a2dacad22da650a8
  • ▲
    Executives
    10M INR3SEBI
    31,000 shares@ ₹329.914610.6% of flowEquity SharesSEBI:5414cec9427508777dcc1e3cbb30cadbfe1a2de7
    Canonical exit: 25 Sept 2022 (T+90)
  • ▲
    Executives
    989,309 INR2SEBI
    3,000 shares@ ₹329.76971.0% of flowEquity SharesSEBI:f8874a30654e2da63378671d73bd0c406297b1c7
    Canonical exit: 21 Sept 2022 (T+90)
  • ▲
    Executives
    10M INR3SEBI
    30,000 shares@ ₹327.024110.2% of flowEquity SharesSEBI:43efe28e89efe6670a8b7e4b97819160c28e7175
    Canonical exit: 20 Sept 2022 (T+90)
  • ▲
    Executives
    3M INR2SEBI
    9,000 shares@ ₹329.86433.1% of flowEquity SharesSEBI:cf6fac8f5786deef0646fa2eac026a2515c6d3bf
    Canonical exit: 19 Sept 2022 (T+90)
  • ▲
    Executives
    9M INR3SEBI
    28,070 shares@ ₹328.81639.7% of flowEquity SharesSEBI:7e7979d5b80c4cc51d7e1c2a80089fd69f810197
    Canonical exit: 18 Sept 2022 (T+90)
  • ▲
    Executives
    21M INR4SEBI
    63,930 shares@ ₹328.805322.0% of flowEquity SharesSEBI:46df664a3194b41bbe6da0beca6eee3442f15b41
    Canonical exit: 14 Sept 2022 (T+90)
  • ▲
    Executives
    25M INR5SEBI
    82,000 shares@ ₹309.461126.7% of flowEquity SharesSEBI:4a11f9688b0b4a255453703e6fafe0168ec6866f
    Canonical exit: 13 Sept 2022 (T+90)
  • ▲
    Executives
    16M INR4SEBI
    53,000 shares@ ₹300.223216.8% of flowEquity SharesSEBI:fbf6a3053fef474c82042390091b1cdb51e9bca2
    Canonical exit: 12 Sept 2022 (T+90)

11 of 11 declarations

About Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited is a company specializing in medical diagnostic services in India. It offers a wide range of tests and analyses for patients.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations